Artificial Vital Organs And Medical Bionics Global Market Report 2026
상품코드:1939278
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
인공 장기 및 의료용 바이오닉스 시장 규모는 최근 현저한 성장을 달성하고 있습니다. 2025년 469억 5,000만 달러에서 2026년에는 510억 7,000만 달러로, CAGR 8.8%로 확대가 전망되고 있습니다. 지금까지의 성장 요인으로는 인공장기 기술의 제한적인 보급, 초기 바이오닉 디바이스의 높은 비용, 기계식 장기 시스템에 대한 의존도, 장기부전 증가 추세, 의료용 바이오닉 디바이스에 대한 초기 규제 승인 등을 꼽을 수 있습니다.
인공 중요 장기 및 의료용 바이오닉스 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 706억 7,000만 달러에 달하며, CAGR은 8.5%에 달할 전망입니다. 예측 기간 중의 성장 요인으로는 전자 및 스마트 바이오닉 디바이스의 발전, 인공장기 연구개발 투자 증가, 최소침습적 이식 수술의 보급 확대, 맞춤형 의료 및 환자 맞춤형 솔루션의 성장, 바이오닉 치료를 제공하는 병원 및 클리닉의 확대 등을 꼽을 수 있습니다. 예측 기간 중 주요 동향으로는 인공 심장 및 신장 장치의 채택 확대, 신경 임플란트와 바이오닉 장기의 통합 발전, 재활 및 보조 기술의 성장, 맞춤형 환자 맞춤형 솔루션에 대한 집중, 임상시험 및 연구용 용도의 확대 등을 들 수 있습니다.
장기부전 유병률 증가는 향후 인공 중요 장기 및 의료용 바이오닉스 시장의 성장을 가속할 것으로 예측됩니다. 장기부전은 하나 이상의 장기가 필수적인 기능을 상실하여 심각한 건강 합병증이나 생명을 위협하는 결과를 초래할 수 있는 심각한 상태입니다. 장기부전 증가는 당뇨병, 고혈압, 심장병과 같은 만성질환 증가율과 장기부전에 기여하는 유전적 질환 및 유전적 소인에 의해 촉진되고 있습니다. 인공 중요 장기 및 의료용 바이오닉스는 손상된 장기를 가진 환자에게 생명 유지 지원을 제공하고, 중요한 기능을 회복시켜 장기 부전 관리에 기여합니다. 예를 들어 미국에 기반을 둔 비영리 장기 기증 및 이식 시스템인 장기 조달 이식 네트워크(OPTN)에 따르면 2025년 1월 기준 2024년 장기 이식 건수는 4만 8,000건을 넘어섰으며, 2023년 시행 건수 대비 3.3% 증가한 것으로 나타났습니다. 따라서 장기 부전 증가 추세는 인공 중요 장기 및 의료용 바이오닉스 시장의 성장을 촉진하고 있습니다.
고령화 사회의 진전은 향후 인공 중요 장기 및 의료용 바이오닉스 시장의 성장을 가속할 것으로 예측됩니다. 노년층은 60세 또는 65세 이상의 개인을 의미하며, 노화에 따른 건강 문제 및 생활습관 문제로 인해 개별화된 케어와 서비스가 필요한 연령층입니다. 의료시스템의 향상과 생활수준의 향상으로 평균 수명이 길어지면서 노인 인구는 증가 추세에 있습니다. 인공 중요 장기 및 의료용 바이오닉스는 쇠퇴하는 생체 기능을 대체하거나 강화하여 노년층의 이동성, 독립성, 삶의 질 향상에 기여합니다. 예를 들어 연구 및 학술적 활용을 위한 통계 데이터 수집을 담당하는 미국 비영리단체 '인구문제연구소'가 2024년 1월 발표한 보고서에 따르면 65세 이상 미국 인구는 2022년 5,800만 명에서 2050년까지 8,200만 명으로 47% 증가할 것으로 예상했습니다. 그 결과, 이 연령대가 미국 전체 인구에서 차지하는 비중은 같은 기간 중 17%에서 23%로 증가합니다. 따라서 고령 인구 증가가 인공장기 및 의료용 바이오닉스 시장의 성장을 촉진하고 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 용도 산업의 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장의 세계 TAM(Total Addressable Market)
제9장 시장 세분화
제10장 지역별·국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 대기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 합병과 인수
제40장 시장의 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSA
영문 목차
영문목차
Artificial vital organs are engineered devices that replicate the function of essential organs, while medical bionics integrates biological and electronic systems to restore or enhance bodily functions. The primary aim is to sustain life, improve quality of life in cases of severe organ failure, and help recover or enhance lost physical abilities.
The key artificial vital organs and medical bionics consist of artificial vital organs and medical bionics. Artificial vital organs are technologically developed devices that mimic the functions of natural organs such as the heart, lungs, or kidneys to support life in patients experiencing organ failure. These systems may be mechanical or electronic in nature and are commonly used by hospitals, clinics, and other healthcare providers.
Tariffs are impacting the artificial vital organs and medical bionics market by increasing the cost of imported components, such as electronic sensors, mechanical pumps, and specialized biomaterials. Segments like electronic medical bionics and artificial heart devices are particularly impacted, with Asia-Pacific regions including China and India facing higher import duties. This has raised production and procurement costs while causing temporary supply chain disruptions. Positively, tariffs have encouraged local manufacturing, innovation in material sourcing, and investment in domestic production capacities to reduce dependency on imports.
The artificial vital organs and medical bionics market research report is one of a series of new reports from The Business Research Company that provides artificial vital organs and medical bionics market statistics, including artificial vital organs and medical bionics industry global market size, regional shares, competitors with a artificial vital organs and medical bionics market share, detailed artificial vital organs and medical bionics market segments, market trends and opportunities, and any further data you may need to thrive in the artificial vital organs and medical bionics industry. This artificial vital organs and medical bionics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The artificial vital organs and medical bionics market size has grown strongly in recent years. It will grow from $46.95 billion in 2025 to $51.07 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to limited availability of artificial organ technologies, high cost of early bionic devices, reliance on mechanical organ systems, increasing prevalence of organ failure, initial regulatory approvals for medical bionic devices.
The artificial vital organs and medical bionics market size is expected to see strong growth in the next few years. It will grow to $70.67 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to advancements in electronic and smart bionic devices, rising investment in r&d for artificial organs, increasing adoption of minimally invasive implantation procedures, growth in personalized medicine and patient-specific solutions, expansion of hospitals and clinics offering bionic therapies. Major trends in the forecast period include rising adoption of artificial heart and kidney devices, increasing integration of neural implants and bionic organs, growth in rehabilitation and assistive technologies, emphasis on customizable and patient-specific solutions, expansion of clinical trials and research applications.
The rising prevalence of organ failures is expected to propel the growth of the artificial vital organs and medical bionics market going forward. Organ failure is a serious condition in which one or more organs lose their ability to perform essential functions, resulting in severe health complications and potentially life-threatening outcomes. The increase in organ failures is driven by higher rates of chronic conditions such as diabetes, hypertension, and heart disease, as well as inherited conditions and genetic predispositions that contribute to organ failure. Artificial vital organs and medical bionics help manage organ failure by providing life-sustaining support and restoring critical functions in patients with damaged organs. For instance, in January 2025, according to the Organ Procurement and Transplantation Network, a US-based non-profit scientific organ donation and transplantation system, organ transplants exceeded 48,000 in 2024, representing a 3.3% increase from those performed in 2023. Therefore, the rising prevalence of organ failures is driving the growth of the artificial vital organs and medical bionics market.
The rise in the elderly population is expected to drive the growth of the artificial vital organs and medical bionics market going forward. The elderly population consists of individuals aged 60 or 65 and above who require customized care and services due to aging-related health and lifestyle challenges. The elderly population is increasing due to longer life expectancy supported by improved healthcare systems and better living standards. Artificial vital organs and medical bionics support the elderly population by replacing or enhancing declining biological functions, thereby improving mobility, independence, and overall quality of life. For example, in January 2024, according to a report published by Population Reference Bureau, a US-based non-profit organization responsible for collecting statistical data for research and academic use, the number of Americans aged 65 and older is expected to grow from 58 million in 2022 to 82 million by 2050, reflecting a 47% increase. As a result, this age group's share of the total US population will rise from 17% to 23% during this timeframe. Therefore, the increase in the elderly population is driving the growth of the artificial vital organs and medical bionics market.
Major companies operating in the artificial vital organs and medical bionics market are developing advanced products, such as bionic pancreas systems, to improve patient outcomes and meet the increasing demand for innovative medical solutions. A bionic pancreas is a sophisticated medical device designed to automate blood glucose regulation in individuals with diabetes by replicating the functions of a healthy pancreas. For example, in December 2023, Beta Bionics Inc., a US-based medical technology company, launched the iLet Bionic Pancreas, an autonomous insulin delivery system that simplifies diabetes management by automatically adjusting insulin delivery based on the user's weight. This approach removes the need for healthcare providers to configure complex settings such as insulin-to-carbohydrate ratios, correction factors, or preset basal rates, thereby reducing the burden on both patients and clinicians.
Major companies operating in the artificial vital organs and medical bionics market are Abiomed Inc., Abbott Laboratories, Medtronic Plc, Fresenius Medical Care AG, Asahi Kasei Corporation, Boston Scientific Corporation, Biomet Inc., Terumo Corporation, Edwards Lifesciences Corporation, Otto Bock Healthcare GmbH, Nikkiso Co. Ltd., Cochlear Ltd., Ossur, Cirtec Medical, Heartware International Inc., Berlin Heart GmbH, SynCardia Systems LLC, Ekso Bionics Holdings Inc., Jarvik Heart Inc., CARMAT, Iwalk Inc., BiVACOR Inc., Nano Retina Inc., Second Sight Medical Products Inc., St. Jude Medical Inc.
North America was the largest region in the artificial vital organs and medical bionics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial vital organs and medical bionics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the artificial vital organs and medical bionics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The artificial vital organs and medical bionics market consists of sales of artificial hearts, artificial kidneys, artificial lungs, artificial pancreas, bionic limbs, cochlear implants, retinal implants, neuroprosthetics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Artificial Vital Organs And Medical Bionics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses artificial vital organs and medical bionics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for artificial vital organs and medical bionics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial vital organs and medical bionics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Type: Artificial Vital Organs; Medical Bionics
2) By Technology: Mechanical; Electronic
3) By Application: Hospitals; Clinics; Other Applications
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.2.1 Rising Adoption Of Artificial Heart And Kidney Devices
4.2.2 Increasing Integration Of Neural Implants And Bionic Organs
4.2.3 Growth In Rehabilitation And Assistive Technologies
4.2.4 Emphasis On Customizable And Patient-Specific Solutions
4.2.5 Expansion Of Clinical Trials And Research Applications
5. Artificial Vital Organs And Medical Bionics Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Clinics
5.3 Rehabilitation Centers
5.4 Research Institutions
5.5 Medical Device Manufacturers
6. Artificial Vital Organs And Medical Bionics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Artificial Vital Organs And Medical Bionics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Artificial Vital Organs And Medical Bionics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Artificial Vital Organs And Medical Bionics Market Size, Comparisons And Growth Rate Analysis
7.3. Global Artificial Vital Organs And Medical Bionics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Artificial Vital Organs And Medical Bionics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Artificial Vital Organs And Medical Bionics Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Artificial Vital Organs And Medical Bionics Market Segmentation
9.1. Global Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Artificial Vital Organs, Medical Bionics
9.2. Global Artificial Vital Organs And Medical Bionics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Mechanical, Electronic
9.3. Global Artificial Vital Organs And Medical Bionics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Clinics, Other Applications
9.4. Global Artificial Vital Organs And Medical Bionics Market, Sub-Segmentation Of Artificial Vital Organs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.5. Global Artificial Vital Organs And Medical Bionics Market, Sub-Segmentation Of Medical Bionics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10. Artificial Vital Organs And Medical Bionics Market Regional And Country Analysis
10.1. Global Artificial Vital Organs And Medical Bionics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Artificial Vital Organs And Medical Bionics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Artificial Vital Organs And Medical Bionics Market
11.1. Asia-Pacific Artificial Vital Organs And Medical Bionics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Artificial Vital Organs And Medical Bionics Market
12.1. China Artificial Vital Organs And Medical Bionics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Artificial Vital Organs And Medical Bionics Market
13.1. India Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Artificial Vital Organs And Medical Bionics Market
14.1. Japan Artificial Vital Organs And Medical Bionics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Artificial Vital Organs And Medical Bionics Market
15.1. Australia Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Artificial Vital Organs And Medical Bionics Market
16.1. Indonesia Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Artificial Vital Organs And Medical Bionics Market
17.1. South Korea Artificial Vital Organs And Medical Bionics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Artificial Vital Organs And Medical Bionics Market
18.1. Taiwan Artificial Vital Organs And Medical Bionics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Artificial Vital Organs And Medical Bionics Market
19.1. South East Asia Artificial Vital Organs And Medical Bionics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Artificial Vital Organs And Medical Bionics Market
20.1. Western Europe Artificial Vital Organs And Medical Bionics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Artificial Vital Organs And Medical Bionics Market
21.1. UK Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Artificial Vital Organs And Medical Bionics Market
22.1. Germany Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Artificial Vital Organs And Medical Bionics Market
23.1. France Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Artificial Vital Organs And Medical Bionics Market
24.1. Italy Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Artificial Vital Organs And Medical Bionics Market
25.1. Spain Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Artificial Vital Organs And Medical Bionics Market
26.1. Eastern Europe Artificial Vital Organs And Medical Bionics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Artificial Vital Organs And Medical Bionics Market
27.1. Russia Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Artificial Vital Organs And Medical Bionics Market
28.1. North America Artificial Vital Organs And Medical Bionics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Artificial Vital Organs And Medical Bionics Market
29.1. USA Artificial Vital Organs And Medical Bionics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Artificial Vital Organs And Medical Bionics Market
30.1. Canada Artificial Vital Organs And Medical Bionics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Artificial Vital Organs And Medical Bionics Market
31.1. South America Artificial Vital Organs And Medical Bionics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Artificial Vital Organs And Medical Bionics Market
32.1. Brazil Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Artificial Vital Organs And Medical Bionics Market
33.1. Middle East Artificial Vital Organs And Medical Bionics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Artificial Vital Organs And Medical Bionics Market
34.1. Africa Artificial Vital Organs And Medical Bionics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Artificial Vital Organs And Medical Bionics Market Regulatory and Investment Landscape
36. Artificial Vital Organs And Medical Bionics Market Competitive Landscape And Company Profiles
36.1. Artificial Vital Organs And Medical Bionics Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Artificial Vital Organs And Medical Bionics Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Artificial Vital Organs And Medical Bionics Market Company Profiles
36.3.1. Abiomed Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Fresenius Medical Care AG Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Asahi Kasei Corporation Overview, Products and Services, Strategy and Financial Analysis
37. Artificial Vital Organs And Medical Bionics Market Other Major And Innovative Companies
Boston Scientific Corporation, Biomet Inc., Terumo Corporation, Edwards Lifesciences Corporation, Otto Bock Healthcare GmbH, Nikkiso Co. Ltd., Cochlear Ltd., Ossur, Cirtec Medical, Heartware International Inc., Berlin Heart GmbH, SynCardia Systems LLC, Ekso Bionics Holdings Inc., Jarvik Heart Inc., CARMAT
38. Global Artificial Vital Organs And Medical Bionics Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Artificial Vital Organs And Medical Bionics Market
40. Artificial Vital Organs And Medical Bionics Market High Potential Countries, Segments and Strategies
40.1 Artificial Vital Organs And Medical Bionics Market In 2030 - Countries Offering Most New Opportunities
40.2 Artificial Vital Organs And Medical Bionics Market In 2030 - Segments Offering Most New Opportunities
40.3 Artificial Vital Organs And Medical Bionics Market In 2030 - Growth Strategies
